DIaMICOM Network Spring School 2014



Similar documents
MEDICAL SCIENCES SPRING SCHOOL. International Research Training Group 1874/1 Diabetic Microvascular Complications

Department of Nephrology and Immunology (Medizinische Klinik II) RWTH University Clinic Aachen, Germany

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Small artery tone under control of the endothelium

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Danish Cardiovascular Research Academy. PhD-course: Vascular Biology and Atherothrombosis

Renal Blood Flow GFR. Glomerulus Fluid Flow and Forces. Renal Blood Flow (cont d)

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

ANATOMY & PHYSIOLOGY MODULE 2015/16

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Diabetes mellitus. Lecture Outline

FACULTY POSITIONS Department of Pharmacology and Physiology Drexel University College of Medicine

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Sessions. Workshops. Lectures, discussions and workshops. PhD students, members of the PhD Network of Diabetes and Metabolism, Danish Diabetes Academy

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

How To Get Over A Kidney Condition

Certificate in School of Applied Physiology

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

The Burden Of Diabetes And The Promise Of Biomedical Research

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

Diabetes Mellitus PLAN

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

XVII Paavo Nurmi symposium

Human Health Sciences

FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE. Porto Pirgos Hotel ( Parghelia (VV), Calabria, Italy

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

Specialized Master of Science in Experimental Biomedical Research

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

U.S. Food and Drug Administration

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

How To Identify A Novel Pathway Leading To Myocardial Infarction

STEM CELL FELLOWSHIP

Pharmacology skills for drug discovery. Why is pharmacology important?

Drug Treatment in Type 2 Diabetes with Hypertension

Course Curriculum for Master Degree in Clinical Pharmacy

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Sponsor, Exhibit & Advertise

Introduction. Pathogenesis of type 2 diabetes

2nd MuscleTech Network Workshop. From translational Research to translational Medicine. CONCLUSIONS AND CLOSING REMARKS Dr.

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

J D R F R E Q U E S T S L E T T E R S O F I N T E N T F O R : B I O M AR K E R S O F P AN C R E A T I C B E T A C E L L S T R E S S AN D H E AL T H

Summer School 2011 Berlin SFB Transregio 19

Diabetes and Drug Development

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)

Understanding Diabetes

An Interprofessional Approach to Diabetes Management

Pharmacology Curriculum Transition Present

BSc in Medical Sciences with PHARMACOLOGY

October 17, Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Curriculum Vitae Eric S. Miguelino, M.D. Staff Toxicologist, Department of Public Health, Food and Drug Branch, State of California

Disability Evaluation Under Social Security

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Curriculum Vitae. Christopher R. Martens, Ph.D.

A leader in the development and application of information technology to prevent and treat disease.

Subject Index. Bariatric surgery, obesity management 134

The Influence of Infant Health on Adult Chronic Disease

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Master of Physician Assistant Studies Course Descriptions for Year I

Regional Young Investigator SIC meeting. 5-6 March 2015

Understanding the Pain Trajectory During Treadmill Testing in Peripheral Artery Disease

Midwinter Conference 2015 January Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by

Anatomy and Physiology (ANPY) CTY Course Syllabus

COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

Neal Rouzier responds to the JAMA article on Men and Testosterone

EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

SHORT CLINICAL GUIDELINE SCOPE

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

International Conference on Medical Rehabilitation and Prevention of Blindness. November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM

Milwaukee School of Engineering Case Study: Factors that Affect Blood Pressure Instructor Version

This information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.

ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes

The Evolution of Graduate Education in the College of Medicine. Office of Graduate & Postdoctoral Affairs School of Basic Biomedical Sciences

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Course outline. Code: MLS211 Title: Medical Biochemistry

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours

Master BioMedical Sciences (BMS) Track Cell Biology and Advanced Microscopy

Transcription:

DIaMICOM Network Spring School 2014 GrK 1874 Diabetic Microvascular Complications: DIaMICOM Mannheim Groningen (Hans-Peter Hammes, Han Moshage) GrK 1566 Protecting the Heart from Ischemia: PrOMISE Giessen - Barcelona (Klaus T. Preissner) GrK 1508 arterial remodeling: EuCar Aachen - Maastricht (Jürgen Bernhagen)

Organizing committee Prof. Dr. H.-P. Hammes V. Med. Klinik, Universitätsmedizin Mannheim Prof. Dr. H. Moshage Director of Graduate School GUIDE, Medical Dept., UMCG Prof. Dr. J.-L. Hillebrands Dept. of Pathology & Medical Biology - Pathology, UMCG Dr. G. Krenning Dept. of Pathology & Medical Biology Medical Biology, UMCG Prof. Dr. J. Kroll Dept. of Vascular Biology & Tumorangiogenesis Universitätsmedizin Mannheim Prof. Dr. B. Yard V. Med. Klinik, Universitätsmedizin Mannheim S. Englert Dekanat, Medizinische Fakultät Mannheim Venue Internationales Wissenschaftsforum Heidelberg Universität Heidelberg Hauptstraße 242 69117 Heidelberg Tel.: (06221) 54-36 90 Fax: (06221) 16 58 96 E-Mail: iwh@uni-hd.de www.iwh.uni-hd.de www.iwh.uni-hd.de/md/iwh/angebot/iwh_karte-hell.gif

Programme Sunday, March 30, 2014 17.00 17.15 Welcome & Introduction DIAMICOM: Hans-Peter Hammes PROMISE: Klaus T. Preissner EuCAR: Jürgen Bernhagen Moderation: Hot Topic I Robin Jonas & Vincenzo Terlizzi 17.15 17.40 Glyoxalase-1 and microvascular complications in diabetes Caspar Schalkwijk (EuCAR) Session 1 Kidney - Sweet dreams for kidneys, a nightmare for renal cells 17.40 17.55 The function of the Rac1 regulator ELMO1 in the vasculature and in renal development under high glucose in zebrafish and in human diabetic nephropathy Krishna R. Sharma (DIAMICOM) 17.55 18.10 Oxidative protein modification in diabetic nephropathy friend or foe? Tanja Wiedenmann (DIAMICOM) 18.10 18.25 Carnosinase in hyperglycemia: Influence on CN-1 secretion and relevance for damage to glomerular endothelial cells Shiqi Zhang (DIAMICOM) 18.25 18.40 Diabetic nephropathy in the BTBR Ob/Ob mouse as a pre-clinical model for therapeutic interventions Thomas Albrecht (DIAMICOM) 18.40 19.30 Dinner Moderation: Klaus Preissner 19.30 20.30 Keynote lecture Novel potential mediators and biomarkers in diabetic nephropathy Gabriella Gruden

Programme Monday, March 31, 2014 Session 2 More than meets the Eye Moderation: Thomas Albrecht & Bettina Müller 8.30 9.30 Keynote lecture How do policy-makers decide which treatments for diabetic retinopathy to fund? Issues and experience from NICE Amanda Adler 9.30 9.45 Hyperglycemic memory mechanisms relevant to the diabetic retina Patrick Friedrichs (DIAMICOM) 9.45 10.00 ADSC: up a Notch to support retinal capillaries Vincenzo Terlizzi (DIAMICOM / Groningen) 10.00 10.15 MicroRNA-induced microangiopathy in diabetes Julian Friedrich (DIAMICOM) 10.15 10.30 Glucose-induced mitochondrial dysfunction in ADSC implications for pericyte function Ghazaleh Hajmousa (DIAMICOM / Groningen) 10.30 11.00 Coffee break Session 3 Vascular I - The bigger not the better Moderation: Siqi Zhang & Bastian Schlickenrieder 11.00 11.25 Long-term inhibition of AP-1 by JDP2 overexpression prevents cardiac hypertrophy after unilateral kidney stenosis but provokes cardiac dysfunction Gerhild Euler (PROMISE) 11.25 11.50 A background Ca2+ entry pathway mediated by TRPC1/ TRPC4 is critical for development of cardiac hypertrophy Marc Freichel (SFB 1118) 11.50 12.05 The calcium-sensing receptor in experimental models of pressure-induced cardiac hypertrophy Elena Dyukova (PROMISE) 12.05 12.20 Role of endothelial junctional adhesion molecule-a (JAM-A) in inflammatory cell recruitment in atherosclerosis Martin Schmitt (EuCAR) 12.20 12.45 A glimpse on IMI SUMMIT Work package 4 activities at Sanofi Thomas Hübschle (Sanofi) 12.50 14.00 Lunch

Programme Session 4 Neuropathy - To feel or not to feel Moderation: Krishna R. Sharma & Julian Friedrich 14.00 15.00 Keynote lecture Diagnosing and managing diabetic neuropathy: Can we do better? Rayaz Malik 15.00 15.15 Altered cell-cell interaction in experimental diabetic neuropathy contributing to pain? Divija Deshpande (DIAMICOM) 15.15 15.30 Diabetic thin fiber neuropathy - objective assessment and mechanism Robin Jonas (DIAMICOM) 15.30 15.45 Identification of tissue specific changes within the nociceptive system in diabetic peripheral neuropathy contribution of TRP channels Bastian Schlickenrieder (DIAMICOM) 15.45 16.15 Coffee break Session 5 Vascular II - Lost in translation Moderation: Jaspal Garg & Nadine Volk 16.15 16.40 Protective versus exacerbating roles of MIF in cardiovascular and metabolic disease Jürgen Bernhagen (EuCAR) 16.40 16.55 The damaging nature of extracellular RNA in atherosclerosis and cardiovascular disease Hector A. Cabrera-Fuentes (PROMISE) 16.55 17.20 Cytoprotective actions of the anti-diabetic drug metformin Han Moshage (DIAMICOM / Groningen) 17.20 17.45 Inflammatory activities of extracellular RNA in the vasculature Silvia Fischer (PROMISE) 17.45 18.10 Predictive value of vascular function for individual susceptibility to end-organ damage: does it also hold in diabetes? Hendrik Buikema (DIAMICOM / Groningen) 18.15 19.30 Dinner Moderation: Hans-Peter Hammes 19.30 20.30 Candlelight lecture Of mice and men: what did we not (yet) learn about diabetes Hans-Georg Joost

Programme Tuesday, April 1, 2014 Session 6 Mechanisms - Highway to hell Moderation: Tanja Wiedenmann & Divija Deshpande 9.00 10.00 Keynote lecture Climate change at sites of diabetic complications: Just looking for alternative fuel sources?, Josephine Forbes 10.00 10.15 Detoxifying enzymes in diabetic target tissues mitochondrial dependent and independent effects of methylglyoxal, Nadine Volk (DIAMICOM) 10.15 10.30 Dysfunction of compartmentalized cyclic AMP signaling in the diabetic vasculature, Jaspal Garg (DIAMICOM) 10.30 10.45 Coffee break 10.45 11.00 Hyperglycemia-induced monocyte-macrophage differentiation, Kondaiah Moganti (DIAMICOM) 11.00 11.15 Kv channels in myogenic and perivascular fat-dependent autoregulation and small artery diabetic dysfunction, Bettina Müller (DIAMICOM) 11.15 11.30 Monocyte differentiation and macrophage plasticity in diabetic conditions, Sarah Riemann (DIAMICOM) Hot Topic II Moderation: Jürgen Bernhagen 11.30 11.55 Development of an accelerated and reliable model of diabetic nephropathy in mice, Tammo Ostendorf (EUCAR) 11.55 12.15 Concluding remarks 12.15 14.00 Lunch & Farewell 14.00 End of Meeting & Departure

Participants Chairmen Prof. Dr. H.-P. Hammes V. Med. Klinik, Universitätsmedizin Mannheim Prof. Dr. H. Moshage Graduate School GUIDE, Medical Dept., University Medical Center Groningen (UMCG) Speakers Dr. A. Adler Addenbrooke s Hospital, University of Cambridge Prof. Dr. J. Bernhagen Institute of Biochemistry and Molecular Cell Biology RWTH Aachen University Prof. Dr. H. Buikema Department of Clinical Pharmacology, UMCG Prof. Dr. G. Euler Department of Physiology, Justus-Liebig-University Gießen Dr. S. Fischer Institute for Biochemistry, Justus-Liebig-University Gießen Prof. Dr. M. Freichel Institute of Pharmacology, Heidelberg University Prof. Dr. J. Forbes Department of Medicine, University of Melbourne Prof. Dr. G. Gruden Department of Internal Medicine, University of Turin Dr. T. Hübschle Diabetes Division, Sanofi-Aventis Deutschland GmbH, Frankfurt a.m. Prof. Dr. H.-G. Joost German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal Prof. Dr. R. Malik School of Clinical & Laboratory Sciences, University of Manchester Prof. Dr. H. Moshage GUIDE, Medical Dept., UMCG Prof. Dr. T. Ostendorf Department of Internal Medicine II, RWTH Aachen University Prof. C. Schalkwijk CARIM, Maastricht University

DIAMICOM Network Spring School 2014